InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,216.22
(
0.04%
)
US TECH 100
17,679.60
(
0.22%
)
Dow Jones
39,459.78
(
0.18%
)
Brent Oil
82.72
(
-1.47%
)
Bitcoin
60,542.50
(
-3.97%
)
Post# of 3167
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Hercules1

Send PM Follow Ignore
Followers 1006
Posts 43275
Boards Moderated 0
Alias Born 03/17/2014

Hercules1

Re: None

Thursday, 10/19/2017 12:43:49 PM

Thursday, October 19, 2017 12:43:49 PM

Post# of 3167
Shares of Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) got a boost, shooting up 63 percent to $2.38 after the company announced Thursday the release of a 99-cent alternative to Allergan PLC (NYSE: AGN)'s Restasis to address the 30 million Americans suffering from Dry Eye Disease.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!